| Year |
Citation |
Score |
| 2023 |
Jia J, Wilson W, Karmaker A, Nishimura A, Otsuka H, Ohara K, Okawa H, McDonald K, Nandi S, Albeck J, Rodriguez R, Zhou P, Nolta JA. Applications of Plant-made Fibroblast Growth Factor for Human Pluripotent Stem Cells. Stem Cells and Development. PMID 38062993 DOI: 10.1089/scd.2023.0135 |
0.39 |
|
| 2023 |
Sun YH, Kao HKJ, Thai PN, Smithers R, Chang CW, Pretto D, Yechikov S, Oppenheimer S, Bedolla A, Chalker BA, Ghobashy R, Nolta JA, Chan JW, Chiamvimonvat N, Lieu DK. The sinoatrial node extracellular matrix promotes pacemaker phenotype and protects automaticity in engineered heart tissues from cyclic strain. Cell Reports. 42: 113505. PMID 38041810 DOI: 10.1016/j.celrep.2023.113505 |
0.471 |
|
| 2023 |
Dave M, Dev A, Somoza RA, Zhao N, Viswanath S, Mina PR, Chirra P, Obmann VC, Mahabeleshwar GH, Menghini P, Johnson BD, Nolta J, Soto C, Osme A, Khuat LT, et al. Mesenchymal stem cells ameliorate inflammation in an experimental model of Crohn's disease via the mesentery. Biorxiv : the Preprint Server For Biology. PMID 37292753 DOI: 10.1101/2023.05.22.541829 |
0.337 |
|
| 2023 |
Viswanathan S, Blanc KL, Ciccocioppo R, Dagher G, Filiano AJ, Galipeau J, Krampera M, Krieger L, Lalu MM, Nolta J, Rodriguez Pardo VM, Shi Y, Tarte K, Weiss DJ, Martin I. An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells (MSC) Committee perspectives on International Standards Organization/Technical Committee 276 Biobanking Standards for bone marrow-MSCs and umbilical cord tissue-derived MSCs for research purposes. Cytotherapy. PMID 37149800 DOI: 10.1016/j.jcyt.2023.04.005 |
0.309 |
|
| 2023 |
Li T, Conroy KL, Kim AM, Halmai J, Gao K, Moreno E, Wang A, Passerini AG, Nolta JA, Zhou P. Role of MEF2C in the Endothelial Cells Derived from Human Induced Pluripotent Stem Cells. Stem Cells (Dayton, Ohio). PMID 36639926 DOI: 10.1093/stmcls/sxad005 |
0.314 |
|
| 2022 |
Weiss DJ, Filiano A, Galipeau J, Khoury M, Krampera M, Lalu M, Blanc KL, Nolta J, Phinney DG, Rocco PRM, Shi Y, Tarte K, Viswanathan S, Martin I. An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells Committee editorial on overcoming limitations in clinical trials of mesenchymal stromal cell therapy for coronavirus disease-19: time for a global registry. Cytotherapy. PMID 36028438 DOI: 10.1016/j.jcyt.2022.07.010 |
0.31 |
|
| 2022 |
Moll G, Ankrum JA, Olson SD, Nolta JA. Improved MSC Minimal Criteria to Maximize Patient Safety: A Call to Embrace Tissue Factor and Hemocompatibility Assessment of MSC Products. Stem Cells Translational Medicine. 11: 2-13. PMID 35641163 DOI: 10.1093/stcltm/szab005 |
0.354 |
|
| 2022 |
Nolta JA. Celebrating 40 Years as the Trusted Source for Stem Cell Manuscripts. Stem Cells (Dayton, Ohio). 40: 1. PMID 35511864 DOI: 10.1093/stmcls/sxab021 |
0.326 |
|
| 2022 |
Deng P, Halmai JANM, Beitnere U, Cameron D, Martinez ML, Lee CC, Waldo JJ, Thongphanh K, Adhikari A, Copping N, Petkova SP, Lee RD, Lock S, Palomares M, O'Geen H, ... ... Nolta JA, et al. An Cell-Based Delivery Platform for Zinc Finger Artificial Transcription Factors in Pre-clinical Animal Models. Frontiers in Molecular Neuroscience. 14: 789913. PMID 35153670 DOI: 10.3389/fnmol.2021.789913 |
0.308 |
|
| 2021 |
Smithers RL, Kao HKJ, Zeigler S, Yechikov S, Nolta JA, Chan JW, Chiamvimonvat N, Lieu DK. Making Heads or Tails of the Large Mammalian Sinoatrial Node Micro-Organization. Circulation. Arrhythmia and Electrophysiology. CIRCEP121010465. PMID 34794338 DOI: 10.1161/CIRCEP.121.010465 |
0.42 |
|
| 2021 |
Park UC, Park SS, Kim BH, Park SW, Kim YJ, Cary W, Anderson JD, Nolta JA, Yu HG. Subretinal versus intravitreal administration of human CD34+ bone marrow-derived stem cells in a rat model of inherited retinal degeneration. Annals of Translational Medicine. 9: 1275. PMID 34532412 DOI: 10.21037/atm-20-4662 |
0.755 |
|
| 2021 |
Viswanathan S, Ciccocioppo R, Galipeau J, Krampera M, Le Blanc K, Martin I, Moniz K, Nolta J, Phinney DG, Shi Y, Szczepiorkowski ZM, Tarte K, Weiss DJ, Ashford P. Consensus International Council for Commonality in Blood Banking Automation-International Society for Cell & Gene Therapy statement on standard nomenclature abbreviations for the tissue of origin of mesenchymal stromal cells. Cytotherapy. PMID 34116944 DOI: 10.1016/j.jcyt.2021.04.009 |
0.341 |
|
| 2021 |
Nativ-Zeltzer N, Kuhn MA, Evangelista L, Anderson JD, Nolta JA, Farwell DG, Canestrari E, Jankowski RJ, Belafsky PC. Autologous Muscle-Derived Cell Therapy for Swallowing Impairment in Patients Following Treatment for Head and Neck Cancer. The Laryngoscope. PMID 33988246 DOI: 10.1002/lary.29606 |
0.686 |
|
| 2021 |
Galipeau J, Krampera M, Leblanc K, Nolta JA, Phinney DG, Shi Y, Tarte K, Viswanathan S, Martin I. Mesenchymal stromal cell variables influencing clinical potency: the impact of viability, fitness, route of administration and host predisposition. Cytotherapy. PMID 33714704 DOI: 10.1016/j.jcyt.2020.11.007 |
0.301 |
|
| 2021 |
Nolta JA. Mechanisms of modulation and differentiation in mesenchymal stem/stromal cells. Stem Cells (Dayton, Ohio). 39: 1-2. PMID 33373077 DOI: 10.1002/stem.3321 |
0.361 |
|
| 2021 |
Yarborough M, Tempkin T, Nolta J, Joyce N. The Complex Ethics of First In Human Stem Cell Clinical Trials. Ajob Neuroscience. 3. PMID 24273680 DOI: 10.1080/21507740.2012.675010 |
0.306 |
|
| 2020 |
Yechikov S, Kao HKJ, Chang CW, Pretto D, Zhang XD, Sun YH, Smithers R, Sirish P, Nolta JA, Chan JW, Chiamvimonvat N, Lieu DK. NODAL inhibition promotes differentiation of pacemaker-like cardiomyocytes from human induced pluripotent stem cells. Stem Cell Research. 49: 102043. PMID 33128951 DOI: 10.1016/j.scr.2020.102043 |
0.587 |
|
| 2020 |
Khoury M, Rocco PRM, Phinney DG, Krampera M, Martin I, Viswanathan S, Nolta JA, LeBlanc K, Galipeau J, Weiss DJ. Cell-based therapies for coronavirus disease 2019: proper clinical investigations are essential. Cytotherapy. PMID 32933835 DOI: 10.1016/J.Jcyt.2020.04.089 |
0.384 |
|
| 2020 |
Yang HY, Fierro F, So M, Yoon DJ, Nguyen AV, Gallegos A, Bagood MD, Rojo-Castro T, Alex A, Stewart H, Chigbrow M, Dasu MR, Peavy TR, Soulika AM, Nolta JA, et al. Combination product of dermal matrix, human mesenchymal stem cells, and timolol promotes diabetic wound healing in mice. Stem Cells Translational Medicine. PMID 32720751 DOI: 10.1002/Sctm.19-0380 |
0.359 |
|
| 2020 |
Beegle J, Hendrix K, Maciel H, Nolta JA, Anderson JS. Improvement of motor and behavioral activity in Sandhoff mice transplanted with human CD34+ cells transduced with a HexA/HexB expressing lentiviral vector. The Journal of Gene Medicine. e3205. PMID 32335981 DOI: 10.1002/Jgm.3205 |
0.433 |
|
| 2020 |
Rose M, Gao K, Cortez-Toledo E, Agu E, Hyllen AA, Conroy K, Pan G, Nolta JA, Wang A, Zhou P. Endothelial cells derived from patients' induced pluripotent stem cells for sustained factor VIII delivery and the treatment of hemophilia A. Stem Cells Translational Medicine. PMID 32162786 DOI: 10.1002/Sctm.19-0261 |
0.467 |
|
| 2020 |
Biswas D, Cary W, Nolta JA. PPP2R5D-Related Intellectual Disability and Neurodevelopmental Delay: A Review of the Current Understanding of the Genetics and Biochemical Basis of the Disorder. International Journal of Molecular Sciences. 21. PMID 32074998 DOI: 10.3390/Ijms21041286 |
0.306 |
|
| 2020 |
Nolta JA, Galipeau J, Phinney DG. Improving mesenchymal stem/stromal cell potency and survival: Proceedings from the International Society of Cell Therapy (ISCT) MSC preconference held in May 2018, Palais des Congrès de Montréal, Organized by the ISCT MSC Scientific Committee. Cytotherapy. PMID 32067856 DOI: 10.1016/J.Jcyt.2020.01.004 |
0.479 |
|
| 2020 |
Halmai JANM, Deng P, Gonzalez CE, Coggins NB, Cameron D, Carter JL, Buchanan FKB, Waldo JJ, Lock SR, Anderson JD, O'Geen H, Segal DJ, Nolta J, Fink KD. Artificial escape from XCI by DNA methylation editing of the CDKL5 gene. Nucleic Acids Research. PMID 31925439 DOI: 10.1093/Nar/Gkz1214 |
0.68 |
|
| 2020 |
Cary W, Pham M, Nolta JA. Developing human cellular tools for studying and understanding jordan's syndrome Cytotherapy. 22. DOI: 10.1016/J.Jcyt.2020.03.041 |
0.427 |
|
| 2019 |
Nolta JA. The Age of Immunotherapy - Celebrating Stem Cells' Contribution to Understanding Mechanisms of Immune System Development and Modulation. Stem Cells (Dayton, Ohio). PMID 31851396 DOI: 10.1002/Stem.3137 |
0.389 |
|
| 2019 |
Yazdanyar A, Zhang P, Dolf C, Smit-McBride Z, Cary W, Nolta JA, Zawadzki RJ, Marsh-Armstrong N, Park SS. Effects of intravitreal injection of human CD34 bone marrow stem cells in a murine model of diabetic retinopathy. Experimental Eye Research. 107865. PMID 31682846 DOI: 10.1016/J.Exer.2019.107865 |
0.374 |
|
| 2019 |
Marusina AI, Merleev AA, Luna JI, Olney L, Haigh NE, Yoon D, Guo C, Ovadia EM, Shimoda M, Luxardi G, Boddu S, Lal NN, Takada Y, Lam KS, Liu R, ... ... Nolta JA, et al. Tunable hydrogels for mesenchymal stem cell delivery: integrin-induced transcriptome alterations and hydrogel optimization for human wound healing. Stem Cells (Dayton, Ohio). PMID 31648388 DOI: 10.1002/Stem.3105 |
0.473 |
|
| 2019 |
Viswanathan S, Shi Y, Galipeau J, Krampera M, Leblanc K, Martin I, Nolta J, Phinney DG, Sensebe L. Mesenchymal stem versus stromal cells: International Society for Cellular Therapy Mesenchymal Stromal Cell committee position statement on nomenclature. Cytotherapy. PMID 31526643 DOI: 10.1016/J.Jcyt.2019.08.002 |
0.508 |
|
| 2019 |
Elahi FM, Farwell DG, Nolta JA, Anderson JD. Concise Review: Preclinical Translation of Exosomes Derived from Mesenchymal Stem/Stromal Cells. Stem Cells (Dayton, Ohio). PMID 31381842 DOI: 10.1002/Stem.3061 |
0.775 |
|
| 2019 |
Showalter MR, Wancewicz B, Fiehn O, Archard JA, Clayton S, Wagner J, Deng P, Halmai J, Fink KD, Bauer G, Fury B, Perotti NH, Apperson M, Butters J, Belafsky P, ... ... Nolta JA, et al. Primed mesenchymal stem cells package exosomes with metabolites associated with immunomodulation. Biochemical and Biophysical Research Communications. PMID 30926165 DOI: 10.1016/J.Bbrc.2019.03.119 |
0.771 |
|
| 2019 |
Gao K, Kumar P, Cortez-Toledo E, Hao D, Reynaga L, Rose M, Wang C, Farmer D, Nolta J, Zhou J, Zhou P, Wang A. Potential long-term treatment of hemophilia A by neonatal co-transplantation of cord blood-derived endothelial colony-forming cells and placental mesenchymal stromal cells. Stem Cell Research & Therapy. 10: 34. PMID 30670078 DOI: 10.1186/S13287-019-1138-8 |
0.418 |
|
| 2019 |
Yuan OD, Lin C, Wagner J, Archard J, Deng P, Halmai J, Bauer G, Fink K, Fury B, Perotti N, Walker J, Pollock K, Apperson M, Butters J, Belafsky P, ... ... Nolta JA, et al. Exosomes Derived from Human Primed Mesenchymal Stem Cells Induce Mitosis and Potentiate Growth Factor Secretion. Stem Cells and Development. PMID 30638129 DOI: 10.1089/Scd.2018.0200 |
0.771 |
|
| 2018 |
Cortez-Toledo E, Rose M, Agu E, Dahlenburg H, Yao W, Nolta JA, Zhou P. Enhancing Retention of Mesenchymal Stem Cells with Pro-survival Factors Promotes Angiogenesis in a Mouse Model of Limb Ischemia. Stem Cells and Development. PMID 30398391 DOI: 10.1089/Scd.2018.0090 |
0.447 |
|
| 2018 |
Fierro FA, Magner N, Beegle J, Dahlenburg H, Logan White J, Zhou P, Pepper K, Fury B, Coleal-Bergum DP, Bauer G, Gruenloh W, Annett G, Pifer C, Nolta JA. Mesenchymal stem/stromal cells genetically engineered to produce vascular endothelial growth factor for revascularization in wound healing and ischemic conditions. Transfusion. PMID 30383901 DOI: 10.1111/Trf.14914 |
0.466 |
|
| 2018 |
Shieh AK, Singh SG, Nathe C, Lian E, Haudenschild DR, Nolta JA, Lee CA, Giza E, Kreulen CD. Effects of Micronized Cartilage Matrix on Cartilage Repair in Osteochondral Lesions of the Talus. Cartilage. 1947603518796125. PMID 30156865 DOI: 10.1177/1947603518796125 |
0.382 |
|
| 2018 |
Pham MT, Pollock KM, Rose MD, Cary WA, Stewart HR, Zhou P, Nolta JA, Waldau B. Generation of human vascularized brain organoids. Neuroreport. PMID 29570159 DOI: 10.1097/Wnr.0000000000001014 |
0.358 |
|
| 2018 |
Gao K, Kumar P, Hao D, Reynaga L, Farmer DL, Rose M, Nolta JA, Zhou J, Zhou P, Wang A. Potential Long-Term Treatment of Hemophilia a By Early Postnatal Co-Transplantation of Cord Blood Derived Endothelial Colony-Forming Cells and Placental Mesenchymal Stem Cells Blood. 132: 3318-3318. DOI: 10.1182/Blood-2018-99-117701 |
0.427 |
|
| 2017 |
Feng JF, Liu J, Zhang L, Jiang JY, Russell M, Lyeth BG, Nolta JA, Zhao M. Electrical Guidance of Human Stem Cells in the Rat Brain. Stem Cell Reports. PMID 28669601 DOI: 10.1016/J.Stemcr.2017.05.035 |
0.466 |
|
| 2017 |
Moisseiev E, Anderson JD, Oltjen S, Goswami M, Zawadzki RJ, Nolta JA, Park SS. Protective Effect of Intravitreal Administration of Exosomes Derived from Mesenchymal Stem Cells on Retinal Ischemia. Current Eye Research. 1-10. PMID 28636406 DOI: 10.1080/02713683.2017.1319491 |
0.769 |
|
| 2017 |
Kuhn MA, Black AB, Siddiqui MT, Nolta JA, Belafsky PC. Novel murine xenograft model for the evaluation of stem cell therapy for profound dysphagia. The Laryngoscope. PMID 28543406 DOI: 10.1002/Lary.26666 |
0.443 |
|
| 2017 |
Fierro FA, Nolta JA, Adamopoulos IE. Concise Review: Stem Cells in Osteoimmunology. Stem Cells (Dayton, Ohio). 35: 1461-1467. PMID 28390147 DOI: 10.1002/Stem.2625 |
0.441 |
|
| 2017 |
Harding A, Cortez-Toledo E, Magner NL, Beegle JR, Coleal-Bergum DP, Hao D, Wang A, Nolta JA, Zhou P. Highly Efficient Differentiation of Endothelial Cells from Pluripotent Stem Cells Requires the MAPK and the PI3K Pathways. Stem Cells (Dayton, Ohio). PMID 28248004 DOI: 10.1002/Stem.2577 |
0.5 |
|
| 2017 |
Nolta JA. Cutting Edge Advances in Stem Cell Biology and Therapy. Stem Cells (Dayton, Ohio). 35: 1-2. PMID 27873381 DOI: 10.1002/Stem.2547 |
0.446 |
|
| 2017 |
Yang H, So M, Fierro F, Stewart H, Vu Nguyen A, Soulika A, Nolta J, Isseroff R. 928 Combination bioengineered wound scaffolds containing timolol-preconditioned mesenchymal stem cells promote wound healing in diabetic mice Journal of Investigative Dermatology. 137: S160. DOI: 10.1016/J.Jid.2017.02.955 |
0.365 |
|
| 2016 |
Park SS, Moisseiev E, Bauer G, Anderson JD, Grant MB, Zam A, Zawadzki RJ, Werner JS, Nolta JA. Advances in bone marrow stem cell therapy for retinal dysfunction. Progress in Retinal and Eye Research. PMID 27784628 DOI: 10.1016/J.Preteyeres.2016.10.002 |
0.783 |
|
| 2016 |
Beegle JR, Magner NL, Kalomoiris S, Harding A, Zhou P, Nacey C, White JL, Pepper K, Gruenloh W, Annett G, Nolta JA, Fierro FA. Preclinical evaluation of mesenchymal stem cells overexpressing VEGF to treat critical limb ischemia. Molecular Therapy. Methods & Clinical Development. 3: 16053. PMID 27610394 DOI: 10.1038/Mtm.2016.53 |
0.431 |
|
| 2016 |
Moisseiev E, Smit-McBride Z, Oltjen S, Zhang P, Zawadzki RJ, Motta M, Murphy CJ, Cary W, Annett G, Nolta JA, Park SS. Intravitreal Administration of Human Bone Marrow CD34+ Stem Cells in a Murine Model of Retinal Degeneration. Investigative Ophthalmology & Visual Science. 57: 4125-4135. PMID 27537262 DOI: 10.1167/Iovs.16-19252 |
0.466 |
|
| 2016 |
Satake N, Duong C, Yoshida S, Oestergaard M, Chen C, Peralta R, Guo S, Seth PP, Li Y, Beckett L, Chung J, Nolta J, Nitin N, Tuscano JM. Novel Targeted Therapy for Precursor B Cell Acute Lymphoblastic Leukemia: anti-CD22 Antibody-MXD3 Antisense Oligonucleotide Conjugate. Molecular Medicine (Cambridge, Mass.). 22. PMID 27455414 DOI: 10.1182/Blood.V124.21.3719.3719 |
0.401 |
|
| 2016 |
Deng P, Torrest A, Pollock K, Dahlenburg H, Annett G, Nolta JA, Fink KD. Clinical trial perspective for adult and juvenile Huntington's disease using genetically-engineered mesenchymal stem cells. Neural Regeneration Research. 11: 702-5. PMID 27335539 DOI: 10.4103/1673-5374.182682 |
0.417 |
|
| 2016 |
Deng P, Anderson JD, Yu AS, Annett G, Fink KD, Nolta JA. Engineered BDNF producing cells as a potential treatment for neurologic disease. Expert Opinion On Biological Therapy. PMID 27159050 DOI: 10.1080/14712598.2016.1183641 |
0.711 |
|
| 2016 |
Nolta JA. "Next-generation" mesenchymal stem or stromal cells for the in vivo delivery of bioactive factors: progressing toward the clinic. Transfusion. 56: 15S-7S. PMID 27079315 DOI: 10.1111/Trf.13564 |
0.48 |
|
| 2016 |
Kalomoiris S, Cicchetto AC, Lakatos K, Nolta JA, Fierro FA. Fibroblast Growth Factor 2 Regulates High Mobility Group A2 Expression in Human Bone Marrow-Derived Mesenchymal Stem Cells. Journal of Cellular Biochemistry. 117: 2128-37. PMID 26888666 DOI: 10.1002/Jcb.25519 |
0.489 |
|
| 2016 |
Fink KD, Deng P, Gutierrez J, Anderson JS, Torrest A, Komarla A, Kalomoiris S, Cary W, Anderson JD, Gruenloh W, Duffy A, Tempkin T, Wheelock V, Segal DJ, Nolta JA. Allele-specific reduction of the mutant huntingtin allele using transcription activator-like effectors in human Huntington's disease fibroblasts. Cell Transplantation. PMID 26850319 DOI: 10.3727/096368916X690863 |
0.692 |
|
| 2016 |
Anderson JD, Johansson HJ, Graham CS, Vesterlund M, Pham MT, Bramlett CS, Montgomery EN, Mellema MS, Bardini RL, Bauer G, Fink KD, Fury B, Hendrix KJ, Chedin F, El-Andaloussi S, ... ... Nolta JA, et al. Comprehensive Proteomic Analysis of Mesenchymal Stem Cell Exosomes Reveals Modulation of Angiogenesis via NFkB Signaling. Stem Cells (Dayton, Ohio). PMID 26782178 DOI: 10.1002/Stem.2298 |
0.761 |
|
| 2016 |
Pollock K, Dahlenburg H, Nelson H, Fink KD, Cary W, Hendrix K, Annett G, Torrest A, Deng P, Gutierrez J, Nacey C, Pepper K, Kalomoiris S, Anderson JD, McGee JL, ... ... Nolta JA, et al. Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington's disease Mouse Models. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 26765769 DOI: 10.1038/Mt.2016.12 |
0.759 |
|
| 2016 |
Jung Y, Nolta JA. BMI1 Regulation of Self-Renewal and Multipotency in Human Mesenchymal Stem Cells. Current Stem Cell Research & Therapy. 11: 131-40. PMID 26763885 DOI: 10.2174/1574888X1102160107171432 |
0.468 |
|
| 2016 |
Nolta JA. 2015 Year in Review - Advancing the Fields of Stem Cell Biology and Therapy. Stem Cells (Dayton, Ohio). 34: 11-2. PMID 26763480 DOI: 10.1002/Stem.2277 |
0.411 |
|
| 2016 |
Lakatos K, Kalomoiris S, Merkely B, Nolta JA, Fierro FA. Mesenchymal Stem Cells Respond to Hypoxia by Increasing Diacylglycerols. Journal of Cellular Biochemistry. 117: 300-7. PMID 26212931 DOI: 10.1002/Jcb.25292 |
0.469 |
|
| 2016 |
Deng P, Torrest A, Pollock K, Dahlenburg H, Annett G, Nolta JA, Fink KD. Clinical trial perspective for adult and juvenile Huntington’s disease using genetically-engineered mesenchymal stem cells Neural Regeneration Research. 11: 702-705. DOI: 10.4103/1673-5374.182682 |
0.31 |
|
| 2016 |
Anderson JD, Pham MT, Contreras Z, Hoon M, Fink KD, Johansson HJ, Rossignol J, Dunbar GL, Showalter M, Fiehn O, Bramlett CS, Bardini RL, Bauer G, Fury B, Hendrix KJ, ... ... Nolta JA, et al. Mesenchymal stem cell-based therapy for ischemic stroke Chinese Neurosurgical Journal. 2. DOI: 10.1186/S41016-016-0053-4 |
0.732 |
|
| 2016 |
Nolta JA. "next-generation" mesenchymal stem or stromal cells for the in vivo delivery of bioactive factors: Progressing toward the clinic Transfusion. 56: 15S-17S. DOI: 10.1111/trf.13564 |
0.379 |
|
| 2016 |
Nguyen C, Tartar D, So M, Nolta J, Isseroff R. 753 Serotonin as a potential therapeutic target for mesenchymal stem cell – Mediated improvement of wound healing Journal of Investigative Dermatology. 136: S133. DOI: 10.1016/J.JID.2016.02.796 |
0.311 |
|
| 2016 |
Kalomoiris S, Cicchetto AC, Lakatos K, Nolta JA, Fierro FA. Fibroblast Growth Factor 2 Regulates High Mobility Group A2 Expression in Human Bone Marrow-Derived Mesenchymal Stem Cells Journal of Cellular Biochemistry. DOI: 10.1002/jcb.25519 |
0.39 |
|
| 2016 |
Jung Y, Nolta JA. BMI1 regulation of self-renewal and multipotency in human mesenchymal stem cells Current Stem Cell Research and Therapy. 11: 131-140. |
0.33 |
|
| 2015 |
Black AB, Dahlenburg H, Pepper K, Nacey C, Pontow S, Kuhn MA, Belafsky PC, Nolta JA. Human Myoblast and Mesenchymal Stem Cell Interactions Visualized by Videomicroscopy. Human Gene Therapy Methods. PMID 26544924 DOI: 10.1089/Hgtb.2015.100 |
0.507 |
|
| 2015 |
Kol A, Arzi B, Athanasiou KA, Farmer DL, Nolta JA, Rebhun RB, Chen X, Griffiths LG, Verstraete FJ, Murphy CJ, Borjesson DL. Companion animals: Translational scientist's new best friends. Science Translational Medicine. 7: 308ps21. PMID 26446953 DOI: 10.1126/Scitranslmed.Aaa9116 |
0.308 |
|
| 2015 |
McMahill BG, Spriet M, Sisó S, Manzer MD, Mitchell G, McGee J, Garcia TC, Borjesson DL, Sieber-Blum M, Nolta JA, Sturges BK. Feasibility Study of Canine Epidermal Neural Crest Stem Cell Transplantation in the Spinal Cords of Dogs. Stem Cells Translational Medicine. 4: 1173-86. PMID 26273065 DOI: 10.5966/Sctm.2015-0018 |
0.34 |
|
| 2015 |
Vapniarsky N, Arzi B, Hu JC, Nolta JA, Athanasiou KA. Concise Review: Human Dermis as an Autologous Source of Stem Cells for Tissue Engineering and Regenerative Medicine. Stem Cells Translational Medicine. 4: 1187-98. PMID 26253713 DOI: 10.5966/Sctm.2015-0084 |
0.435 |
|
| 2015 |
Fink KD, Deng P, Torrest A, Stewart H, Pollock K, Gruenloh W, Annett G, Tempkin T, Wheelock V, Nolta JA. Developing stem cell therapies for juvenile and adult-onset Huntington's disease. Regenerative Medicine. 10: 623-46. PMID 26237705 DOI: 10.2217/Rme.15.25 |
0.487 |
|
| 2015 |
Sheu J, Beltzer J, Fury B, Wilczek K, Tobin S, Falconer D, Nolta J, Bauer G. Large-scale production of lentiviral vector in a closed system hollow fiber bioreactor. Molecular Therapy. Methods & Clinical Development. 2: 15020. PMID 26151065 DOI: 10.1038/Mtm.2015.20 |
0.341 |
|
| 2015 |
Cary WA, Hori CN, Trananh M, Nacey CA, McGee JL, Hamou M, Berman RF, Bauer G, Nolta JA, Waldau B. Efficient Generation of Induced Pluripotent Stem and Neural Progenitor Cells from Acutely Harvested Dura Mater Obtained during Ventriculoperitoneal Shunt Surgery. World Neurosurgery. PMID 26074438 DOI: 10.1016/J.Wneu.2015.05.076 |
0.444 |
|
| 2015 |
Osborn SL, So M, Hambro S, Nolta JA, Kurzrock EA. Inosculation of blood vessels allows early perfusion and vitality of bladder grafts--implications for bioengineered bladder wall. Tissue Engineering. Part A. 21: 1906-15. PMID 25794892 DOI: 10.1089/Ten.Tea.2014.0630 |
0.32 |
|
| 2015 |
Beegle J, Lakatos K, Kalomoiris S, Stewart H, Isseroff RR, Nolta JA, Fierro FA. Hypoxic preconditioning of mesenchymal stromal cells induces metabolic changes, enhances survival, and promotes cell retention in vivo. Stem Cells (Dayton, Ohio). 33: 1818-28. PMID 25702874 DOI: 10.1002/Stem.1976 |
0.48 |
|
| 2015 |
Chang AI, Schwertschkow AH, Nolta JA, Wu J. Involvement of mesenchymal stem cells in cancer progression and metastases. Current Cancer Drug Targets. 15: 88-98. PMID 25619387 DOI: 10.2174/1568009615666150126154151 |
0.429 |
|
| 2015 |
Barisone GA, Satake N, Lewis C, Duong C, Chen C, Lam KS, Nolta J, D?az E. Loss of MXD3 induces apoptosis of Reh human precursor B acute lymphoblastic leukemia cells. Blood Cells, Molecules & Diseases. 54: 329-35. PMID 25554682 DOI: 10.1016/J.Bcmd.2014.12.002 |
0.45 |
|
| 2015 |
Barclay SL, Yang Y, Zhang S, Fong R, Barraza A, Nolta JA, Torbett BE, Abedi M, Bauer G, Anderson JS. Safety and efficacy of a tCD25 preselective combination anti-HIV lentiviral vector in human hematopoietic stem and progenitor cells. Stem Cells (Dayton, Ohio). 33: 870-9. PMID 25524029 DOI: 10.1002/Stem.1919 |
0.386 |
|
| 2015 |
Park SS, Bauer G, Abedi M, Pontow S, Panorgias A, Jonnal R, Zawadzki RJ, Werner JS, Nolta J. Intravitreal autologous bone marrow CD34+ cell therapy for ischemic and degenerative retinal disorders: preliminary phase 1 clinical trial findings. Investigative Ophthalmology & Visual Science. 56: 81-9. PMID 25491299 DOI: 10.1167/Iovs.14-15415 |
0.436 |
|
| 2015 |
Nolta JA. New advances in understanding stem cell fate and function. Stem Cells (Dayton, Ohio). 33: 313-5. PMID 25446041 DOI: 10.1002/Stem.1905 |
0.456 |
|
| 2015 |
McMahill BG, Borjesson DL, Sieber-Blum M, Nolta JA, Sturges BK. Stem cells in canine spinal cord injury--promise for regenerative therapy in a large animal model of human disease. Stem Cell Reviews. 11: 180-93. PMID 25173879 DOI: 10.1007/S12015-014-9553-9 |
0.391 |
|
| 2015 |
Barclay SL, Yang Y, Zhang S, Fong R, Barraza A, Nolta JA, Abedi M, Anderson JS. 296. Pre-Selection of Anti-HIV Lentiviral Vector Gene Modified Hematopoietic Stem Cells Significantly Improves Protection from HIV Infection: The Basis for a Future Clinical Trial Molecular Therapy. 23: S119. DOI: 10.1016/S1525-0016(16)33905-3 |
0.406 |
|
| 2015 |
Beegle JR, Kalomoiris S, Magner NL, Nolta JA, Fierro FA. 32. Safety Studies Towards a Combined Cell and Gene Therapy To Treat Critical Limb Ischemia Molecular Therapy. 23: S14. DOI: 10.1016/S1525-0016(16)33636-X |
0.421 |
|
| 2015 |
Fury B, Hackett T, Fierro F, Nolta J, Bauer G. Clinically relevant formulation and conditions for transportation of genetically modified bone marrow mesenchymal stem cells engineered to overexpress vascular endothelial growth factor Cytotherapy. 17: S42. DOI: 10.1016/J.Jcyt.2015.03.453 |
0.395 |
|
| 2014 |
Gao W, Zhou P, Ma X, Tschudy-Seney B, Chen J, Magner NL, Revzin A, Nolta JA, Zern MA, Duan Y. Ethanol negatively regulates hepatic differentiation of hESC by inhibition of the MAPK/ERK signaling pathway in vitro. Plos One. 9: e112698. PMID 25393427 DOI: 10.1371/Journal.Pone.0112698 |
0.324 |
|
| 2014 |
Satake N, Duong C, Chen C, Barisone GA, Diaz E, Tuscano J, Rocke DM, Nolta J, Nitin N. Targeted therapy with MXD3 siRNA, anti-CD22 antibody and nanoparticles for precursor B-cell acute lymphoblastic leukaemia. British Journal of Haematology. 167: 487-99. PMID 25196579 DOI: 10.1111/Bjh.13066 |
0.374 |
|
| 2014 |
Clark EA, Kalomoiris S, Nolta JA, Fierro FA. Concise review: MicroRNA function in multipotent mesenchymal stromal cells. Stem Cells (Dayton, Ohio). 32: 1074-82. PMID 24860868 DOI: 10.1002/Stem.1623 |
0.311 |
|
| 2014 |
Dasu MR, Ramirez SR, La TD, Gorouhi F, Nguyen C, Lin BR, Mashburn C, Stewart H, Peavy TR, Nolta JA, Isseroff RR. Crosstalk between adrenergic and toll-like receptors in human mesenchymal stem cells and keratinocytes: a recipe for impaired wound healing. Stem Cells Translational Medicine. 3: 745-59. PMID 24760207 DOI: 10.5966/Sctm.2013-0200 |
0.392 |
|
| 2014 |
Perez-Cunningham J, Ames E, Smith RC, Peter AK, Naidu R, Nolta JA, Murphy WJ. Natural killer cell subsets differentially reject embryonic stem cells based on licensing. Transplantation. 97: 992-8. PMID 24704665 DOI: 10.1097/Tp.0000000000000063 |
0.506 |
|
| 2014 |
Osborn SL, Thangappan R, Luria A, Lee JH, Nolta J, Kurzrock EA. Induction of human embryonic and induced pluripotent stem cells into urothelium. Stem Cells Translational Medicine. 3: 610-9. PMID 24657961 DOI: 10.5966/Sctm.2013-0131 |
0.528 |
|
| 2014 |
Gericota B, Anderson JS, Mitchell G, Borjesson DL, Sturges BK, Nolta JA, Sieber-Blum M. Canine epidermal neural crest stem cells: characterization and potential as therapy candidate for a large animal model of spinal cord injury. Stem Cells Translational Medicine. 3: 334-45. PMID 24443004 DOI: 10.5966/Sctm.2013-0129 |
0.48 |
|
| 2014 |
Nolta JA. Editorial: 2013 - a year of clinical success and great scientific innovation in the stem cell field. Stem Cells (Dayton, Ohio). 32: 1-2. PMID 24375745 DOI: 10.1002/Stem.1602 |
0.511 |
|
| 2014 |
Lee JK, Responte DJ, Cissell DD, Hu JC, Nolta JA, Athanasiou KA. Clinical translation of stem cells: insight for cartilage therapies. Critical Reviews in Biotechnology. 34: 89-100. PMID 24083452 DOI: 10.3109/07388551.2013.823596 |
0.492 |
|
| 2014 |
Plowman EK, Bijangi-Vishehsaraei K, Halum S, Cates D, Hanenberg H, Domer AS, Nolta JA, Belafsky PC. Autologous myoblasts attenuate atrophy and improve tongue force in a denervated tongue model: a pilot study. The Laryngoscope. 124: E20-6. PMID 23929623 DOI: 10.1002/Lary.24352 |
0.343 |
|
| 2014 |
Satake N, Duong C, Yoshida S, Davis R, Liu S, Van Dyke J, McLaughlin B, Nolta JA, Nitin N, Tepper C. Leukemia Stem Cells in Acute Lymphoblastic Leukemia: Unveiling Hierarchical Structure at Single Cell Resolution Blood. 124: 4786-4786. DOI: 10.1182/Blood.V124.21.4786.4786 |
0.468 |
|
| 2014 |
Satake N, Duong C, Oestergaard M, Yoshida S, Chen C, Nolta JA, Guo S, Seth P, Nitin N, Tuscano J. Novel Targeted Therapy for Precursor B Cell Acute Lymphoblastic Leukemia: Anti-CD22 Antibody-MXD3 Antisense Oligonucleotide Conjugates Blood. 124: 3719-3719. DOI: 10.1182/blood.v124.21.3719.3719 |
0.306 |
|
| 2014 |
Duong C, Chen C, Yoshida S, Barisone G, Nolta J, Diaz E, Nitin N, Satake N. Abstract 5423: Novel targeted therapy for neuroblastoma: Silencing the MXD3 gene using siRNA Cancer Research. 74: 5423-5423. DOI: 10.1158/1538-7445.Am2014-5423 |
0.348 |
|
| 2013 |
Yik JH, Li H, Acharya C, Kumari R, Fierro F, Haudenschild DR, Nolta J, Di Cesare PE. The Oncogene LRF Stimulates Proliferation of Mesenchymal Stem Cells and Inhibits Their Chondrogenic Differentiation. Cartilage. 4: 329-38. PMID 26069677 DOI: 10.1177/1947603513497570 |
0.477 |
|
| 2013 |
Binder BY, Sondergaard CS, Nolta JA, Leach JK. Lysophosphatidic acid enhances stromal cell-directed angiogenesis. Plos One. 8: e82134. PMID 24312635 DOI: 10.1371/Journal.Pone.0082134 |
0.405 |
|
| 2013 |
Magner NL, Jung Y, Wu J, Nolta JA, Zern MA, Zhou P. Insulin and IGFs enhance hepatocyte differentiation from human embryonic stem cells via the PI3K/AKT pathway. Stem Cells (Dayton, Ohio). 31: 2095-103. PMID 23836547 DOI: 10.1002/Stem.1478 |
0.371 |
|
| 2013 |
Yao W, Guan M, Jia J, Dai W, Lay YA, Amugongo S, Liu R, Olivos D, Saunders M, Lam KS, Nolta J, Olvera D, Ritchie RO, Lane NE. Reversing bone loss by directing mesenchymal stem cells to bone. Stem Cells (Dayton, Ohio). 31: 2003-14. PMID 23818248 DOI: 10.1002/Stem.1461 |
0.359 |
|
| 2013 |
Annett G, Bauer G, Nolta JA. Mesenchymal stem cells for trinucleotide repeat disorders. Methods in Molecular Biology (Clifton, N.J.). 1010: 79-91. PMID 23754220 DOI: 10.1007/978-1-62703-411-1_6 |
0.488 |
|
| 2013 |
Ma X, Duan Y, Tschudy-Seney B, Roll G, Behbahan IS, Ahuja TP, Tolstikov V, Wang C, McGee J, Khoobyari S, Nolta JA, Willenbring H, Zern MA. Highly efficient differentiation of functional hepatocytes from human induced pluripotent stem cells. Stem Cells Translational Medicine. 2: 409-19. PMID 23681950 DOI: 10.5966/Sctm.2012-0160 |
0.444 |
|
| 2013 |
Dao MA, Nolta JA, Case CC. Immunosuppressive activity of adult marrow mesenchymal stromal cells on innate immune cells in the central nervous system Advances in Neuroimmune Biology. 4: 177-185. DOI: 10.3233/Nib-130064 |
0.451 |
|
| 2013 |
Barisone G, Satake N, Lewis C, Duong C, Chan C, Lam K, Nolta J, Diaz E. Abstract 3128: Mxd3 is required for proliferation of human neuroblastoma cells. Cancer Research. 73: 3128-3128. DOI: 10.1158/1538-7445.Am2013-3128 |
0.405 |
|
| 2012 |
Kalomoiris S, Lawson J, Chen RX, Bauer G, Nolta JA, Anderson JS. CD25 preselective anti-HIV vectors for improved HIV gene therapy. Human Gene Therapy Methods. 23: 366-75. PMID 23216020 DOI: 10.1089/Hgtb.2012.142 |
0.32 |
|
| 2012 |
Liu J, Githinji J, Mclaughlin B, Wilczek K, Nolta J. Role of miRNAs in neuronal differentiation from human embryonic stem cell-derived neural stem cells. Stem Cell Reviews. 8: 1129-37. PMID 23054963 DOI: 10.1007/S12015-012-9411-6 |
0.314 |
|
| 2012 |
Kumari R, Li H, Haudenschild DR, Fierro F, Carlson CS, Overn P, Gupta L, Gupta K, Nolta J, Yik JH, Di Cesare PE. The oncogene LRF is a survival factor in chondrosarcoma and contributes to tumor malignancy and drug resistance. Carcinogenesis. 33: 2076-83. PMID 22847180 DOI: 10.1093/Carcin/Bgs254 |
0.345 |
|
| 2012 |
Murphy WJ, Nolta JA. Autoimmune T cells lured to a FASL web of death by MSCs. Cell Stem Cell. 10: 485-7. PMID 22560070 DOI: 10.1016/J.Stem.2012.04.013 |
0.468 |
|
| 2012 |
Walker JE, Chen RX, McGee J, Nacey C, Pollard RB, Abedi M, Bauer G, Nolta JA, Anderson JS. Generation of an HIV-1-resistant immune system with CD34(+) hematopoietic stem cells transduced with a triple-combination anti-HIV lentiviral vector. Journal of Virology. 86: 5719-29. PMID 22398281 DOI: 10.1128/Jvi.06300-11 |
0.39 |
|
| 2012 |
Guan M, Yao W, Liu R, Lam KS, Nolta J, Jia J, Panganiban B, Meng L, Zhou P, Shahnazari M, Ritchie RO, Lane NE. Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass. Nature Medicine. 18: 456-62. PMID 22306732 DOI: 10.1038/Nm.2665 |
0.329 |
|
| 2012 |
Park SS, Caballero S, Bauer G, Shibata B, Roth A, Fitzgerald PG, Forward KI, Zhou P, McGee J, Telander DG, Grant MB, Nolta JA. Long-term effects of intravitreal injection of GMP-grade bone-marrow-derived CD34+ cells in NOD-SCID mice with acute ischemia-reperfusion injury. Investigative Ophthalmology & Visual Science. 53: 986-94. PMID 22247454 DOI: 10.1167/Iovs.11-8833 |
0.358 |
|
| 2012 |
Olson SD, Kambal A, Pollock K, Mitchell GM, Stewart H, Kalomoiris S, Cary W, Nacey C, Pepper K, Nolta JA. Examination of mesenchymal stem cell-mediated RNAi transfer to Huntington's disease affected neuronal cells for reduction of huntingtin. Molecular and Cellular Neurosciences. 49: 271-81. PMID 22198539 DOI: 10.1016/J.Mcn.2011.12.001 |
0.466 |
|
| 2012 |
Armstrong L, Lako M, Buckley N, Lappin TR, Murphy MJ, Nolta JA, Pittenger M, Stojkovic M. Editorial: Our top 10 developments in stem cell biology over the last 30 years. Stem Cells (Dayton, Ohio). 30: 2-9. PMID 22162299 DOI: 10.1002/Stem.1007 |
0.494 |
|
| 2012 |
Olson SD, Pollock K, Kambal A, Cary W, Mitchell GM, Tempkin J, Stewart H, McGee J, Bauer G, Kim HS, Tempkin T, Wheelock V, Annett G, Dunbar G, Nolta JA. Genetically engineered mesenchymal stem cells as a proposed therapeutic for Huntington's disease. Molecular Neurobiology. 45: 87-98. PMID 22161544 DOI: 10.1007/S12035-011-8219-8 |
0.475 |
|
| 2012 |
Feng JF, Liu J, Zhang XZ, Zhang L, Jiang JY, Nolta J, Zhao M. Guided migration of neural stem cells derived from human embryonic stem cells by an electric field. Stem Cells (Dayton, Ohio). 30: 349-55. PMID 22076946 DOI: 10.1002/Stem.779 |
0.463 |
|
| 2012 |
Jung Y, Bauer G, Nolta JA. Concise review: Induced pluripotent stem cell-derived mesenchymal stem cells: progress toward safe clinical products. Stem Cells (Dayton, Ohio). 30: 42-7. PMID 21898694 DOI: 10.1002/Stem.727 |
0.526 |
|
| 2012 |
Segal DJ, Bhakta MS, Das KT, Sun C, Grace NM, Nolta JA, Knowlton AA, Rocke DM, Simon SI. Dissecting the genetic architecture of coronary artery disease by genome engineering Bmc Proceedings. 6. DOI: 10.1186/1753-6561-6-S6-P34 |
0.306 |
|
| 2012 |
Barisone G, Satake N, Lewis C, Lam K, Nolta JA, Diaz E. The Role of MXD3 in Human Precursor B Cell Acute Lymphoblastic Leukemia Blood. 120: 3523-3523. DOI: 10.1182/Blood.V120.21.3523.3523 |
0.432 |
|
| 2012 |
Yarborough M, Tempkin T, Nolta J, Joyce N. The Complex Ethics of First in Human Stem Cell Clinical Trials Ajob Neuroscience. 3: 14-16. DOI: 10.1080/21507740.2012.675010 |
0.315 |
|
| 2012 |
Nolta JA. Stem cells new editor Stem Cells. 30: 1. DOI: 10.1002/Stem.1014 |
0.471 |
|
| 2011 |
Fierro FA, Kalomoiris S, Sondergaard CS, Nolta JA. Effects on proliferation and differentiation of multipotent bone marrow stromal cells engineered to express growth factors for combined cell and gene therapy. Stem Cells (Dayton, Ohio). 29: 1727-37. PMID 21898687 DOI: 10.1002/Stem.720 |
0.44 |
|
| 2011 |
Zhou P, Lessa N, Estrada DC, Severson EB, Lingala S, Zern MA, Nolta JA, Wu J. Decellularized liver matrix as a carrier for the transplantation of human fetal and primary hepatocytes in mice. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. 17: 418-27. PMID 21445925 DOI: 10.1002/Lt.22270 |
0.32 |
|
| 2011 |
Chen X, Lingala S, Khoobyari S, Nolta J, Zern MA, Wu J. Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations. Journal of Hepatology. 55: 838-45. PMID 21334406 DOI: 10.1016/J.Jhep.2010.12.043 |
0.327 |
|
| 2011 |
Gruenloh W, Kambal A, Sondergaard C, McGee J, Nacey C, Kalomoiris S, Pepper K, Olson S, Fierro F, Nolta JA. Characterization and in vivo testing of mesenchymal stem cells derived from human embryonic stem cells. Tissue Engineering. Part A. 17: 1517-25. PMID 21275830 DOI: 10.1182/Blood.V114.22.1451.1451 |
0.45 |
|
| 2011 |
Kambal A, Mitchell G, Cary W, Gruenloh W, Jung Y, Kalomoiris S, Nacey C, McGee J, Lindsey M, Fury B, Bauer G, Nolta JA, Anderson JS. Generation of HIV-1 resistant and functional macrophages from hematopoietic stem cell-derived induced pluripotent stem cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 584-93. PMID 21119622 DOI: 10.1182/Blood.V116.21.562.562 |
0.397 |
|
| 2011 |
Satake N, Thampi S, Tepper C, Chang A, Zhou P, McLaughlin B, McGee J, Nolta JA. Validation of a Human Acute Lymphoblastic Leukemia Mouse Model Using Next Generation RNA Sequencing, Blood. 118: 3576-3576. DOI: 10.1182/Blood.V118.21.3576.3576 |
0.394 |
|
| 2011 |
Satake N, Lee J, Xiao K, Luo J, Sarangi S, Chang A, McLaughlin B, Zhou P, Kenney E, Kraynov L, Arnott S, McGee J, Nolta J, Lam K. Nanoparticle targeted therapy against childhood acute lymphoblastic leukemia Proceedings of Spie - the International Society For Optical Engineering. 8031. DOI: 10.1117/12.885550 |
0.356 |
|
| 2010 |
Joyce N, Annett G, Wirthlin L, Olson S, Bauer G, Nolta JA. Mesenchymal stem cells for the treatment of neurodegenerative disease. Regenerative Medicine. 5: 933-46. PMID 21082892 DOI: 10.2217/Rme.10.72 |
0.459 |
|
| 2010 |
Meyerrose T, Olson S, Pontow S, Kalomoiris S, Jung Y, Annett G, Bauer G, Nolta JA. Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors. Advanced Drug Delivery Reviews. 62: 1167-74. PMID 20920540 DOI: 10.1016/J.Addr.2010.09.013 |
0.491 |
|
| 2010 |
Stojkovic M, Pittenger MF, Nolta JA, Lako M, Lappin TR, Murphy MJ. Stem Cells' position statement on hESC research. Stem Cells (Dayton, Ohio). 28: 1A. PMID 20809560 DOI: 10.1002/Stem.517 |
0.439 |
|
| 2010 |
Sondergaard CS, Hodonsky CJ, Khait L, Shaw J, Sarkar B, Birla R, Bove E, Nolta J, Si MS. Human thymus mesenchymal stromal cells augment force production in self-organized cardiac tissue. The Annals of Thoracic Surgery. 90: 796-803; discussion . PMID 20732499 DOI: 10.1016/J.Athoracsur.2010.04.080 |
0.392 |
|
| 2010 |
Rosová I, Link D, Nolta JA. shRNA-mediated decreases in c-Met levels affect the differentiation potential of human mesenchymal stem cells and reduce their capacity for tissue repair. Tissue Engineering. Part A. 16: 2627-39. PMID 20367286 DOI: 10.1089/Ten.Tea.2009.0363 |
0.43 |
|
| 2010 |
Sondergaard CS, Hess DA, Maxwell DJ, Weinheimer C, Rosová I, Creer MH, Piwnica-Worms D, Kovacs A, Pedersen L, Nolta JA. Human cord blood progenitors with high aldehyde dehydrogenase activity improve vascular density in a model of acute myocardial infarction. Journal of Translational Medicine. 8: 24. PMID 20214792 DOI: 10.1182/Blood.V112.11.2895.2895 |
0.471 |
|
| 2010 |
Satake N, Sarangi S, Chang A, McLaughlin B, Zhou P, Kenny E, Kraynov L, Arnott S, McGee J, Nolta JA, Lam K. Leukemia-Specific Ligands Against Childhood Acute Lymphoblastic leukemia Blood. 116: 3269-3269. DOI: 10.1182/Blood.V116.21.3269.3269 |
0.346 |
|
| 2010 |
Satake N, Chang A, McLaughlin B, Bauman S, Chan J, Sarangi S, Zhou P, Kenny E, Kraynov L, Arnott S, McGee J, Nolta JA. Evaluation of CD9 as a Candidate Leukemia Stem Cell Marker In Childhood Precursor B Cell Acute Lymphoblastic Leukemia Blood. 116: 3241-3241. DOI: 10.1182/Blood.V116.21.3241.3241 |
0.458 |
|
| 2010 |
Roug AS, Nolta JA, Larsen HO, Sondergaard C, Hokland P. Flow Cytometric Detection of Minimal Residual Disease In Acute Myeloid Leukemia – the Addition of hMICL and CD123 Add to Sensitivity and Applicability Blood. 116: 2719-2719. DOI: 10.1182/Blood.V116.21.2719.2719 |
0.309 |
|
| 2010 |
Nolta J. Keynote address—Working Toward Mesenchymal Stem Cell Therapy for HD Neurotherapeutics. 7: 136-136. DOI: 10.1016/J.Nurt.2009.09.028 |
0.415 |
|
| 2010 |
Annett G, Wirthlin L, Pepper K, Sondergaard C, McGee J, Lindsey M, Zhou P, Bauer G, Nolta J. Models Of Stem Cell Transplantation For The Repair Of Non-Hematopoietic Tissues Biology of Blood and Marrow Transplantation. 16: S256. DOI: 10.1016/J.Bbmt.2009.12.307 |
0.451 |
|
| 2009 |
Zhou P, Wirthlin L, McGee J, Annett G, Nolta J. Contribution of human hematopoietic stem cells to liver repair. Seminars in Immunopathology. 31: 411-9. PMID 19533133 DOI: 10.1007/S00281-009-0166-3 |
0.497 |
|
| 2009 |
Zhou P, Hohm S, Olusanya Y, Hess DA, Nolta J. Human progenitor cells with high aldehyde dehydrogenase activity efficiently engraft into damaged liver in a novel model. Hepatology (Baltimore, Md.). 49: 1992-2000. PMID 19437487 DOI: 10.1002/Hep.22862 |
0.439 |
|
| 2009 |
Capoccia BJ, Robson DL, Levac KD, Maxwell DJ, Hohm SA, Neelamkavil MJ, Bell GI, Xenocostas A, Link DC, Piwnica-Worms D, Nolta JA, Hess DA. Revascularization of ischemic limbs after transplantation of human bone marrow cells with high aldehyde dehydrogenase activity. Blood. 113: 5340-51. PMID 19324906 DOI: 10.1182/Blood-2008-04-154567 |
0.504 |
|
| 2009 |
Wirthlin L, Hess D, Zhou P, Nolta J. Human stem cells for tissue repair. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 14: 151-3. PMID 18162236 DOI: 10.1016/J.Bbmt.2007.11.011 |
0.504 |
|
| 2009 |
Sondergaard C, Fierro FA, McGee J, Nolta JA. Assessment of the Impact of Enforced Expression of Platelet Derived Growth Factor Beta in Human Mesenchymal Stem Cells and Contribution to Blood Flow Restoration. Blood. 114: 3568-3568. DOI: 10.1182/Blood.V114.22.3568.3568 |
0.449 |
|
| 2008 |
Rosová I, Dao M, Capoccia B, Link D, Nolta JA. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells (Dayton, Ohio). 26: 2173-82. PMID 18511601 DOI: 10.1634/Stemcells.2007-1104 |
0.438 |
|
| 2008 |
Rich JT, Rosová I, Nolta JA, Myckatyn TM, Sandell LJ, McAlinden A. Upregulation of Runx2 and Osterix during in vitro chondrogenesis of human adipose-derived stromal cells. Biochemical and Biophysical Research Communications. 372: 230-5. PMID 18482578 DOI: 10.1016/J.Bbrc.2008.05.022 |
0.406 |
|
| 2008 |
Bauer G, Dao MA, Case SS, Meyerrose T, Wirthlin L, Zhou P, Wang X, Herrbrich P, Arevalo J, Csik S, Skelton DC, Walker J, Pepper K, Kohn DB, Nolta JA. In vivo biosafety model to assess the risk of adverse events from retroviral and lentiviral vectors. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 1308-15. PMID 18461052 DOI: 10.1182/Blood.V110.11.2595.2595 |
0.406 |
|
| 2008 |
Meyerrose TE, Roberts M, Ohlemiller KK, Vogler CA, Wirthlin L, Nolta JA, Sands MS. Lentiviral-transduced human mesenchymal stem cells persistently express therapeutic levels of enzyme in a xenotransplantation model of human disease. Stem Cells (Dayton, Ohio). 26: 1713-22. PMID 18436861 DOI: 10.1634/Stemcells.2008-0008 |
0.488 |
|
| 2008 |
Bonde J, Wirthlin L, Kohn DB, Nolta JA. Human hematopoietic cell culture, transduction, and analyses. Current Protocols in Human Genetics / Editorial Board, Jonathan L. Haines ... [Et Al.]. Unit 13.7. PMID 18428422 DOI: 10.1002/0471142905.Hg1307S56 |
0.421 |
|
| 2008 |
Zhou P, Hohm S, Capoccia B, Wirthlin L, Hess D, Link D, Nolta J. Immunodeficient mouse models to study human stem cell-mediated tissue repair. Methods in Molecular Biology (Clifton, N.J.). 430: 213-25. PMID 18370302 DOI: 10.1007/978-1-59745-182-6_15 |
0.501 |
|
| 2008 |
Maxwell DJ, Bonde J, Hess DA, Hohm SA, Lahey R, Zhou P, Creer MH, Piwnica-Worms D, Nolta JA. Fluorophore-conjugated iron oxide nanoparticle labeling and analysis of engrafting human hematopoietic stem cells. Stem Cells (Dayton, Ohio). 26: 517-24. PMID 18055451 DOI: 10.1634/Stemcells.2007-0016 |
0.391 |
|
| 2008 |
Hess DA, Craft TP, Wirthlin L, Hohm S, Zhou P, Eades WC, Creer MH, Sands MS, Nolta JA. Widespread nonhematopoietic tissue distribution by transplanted human progenitor cells with high aldehyde dehydrogenase activity. Stem Cells (Dayton, Ohio). 26: 611-20. PMID 18055447 DOI: 10.1634/Stemcells.2007-0429 |
0.46 |
|
| 2008 |
Zhou P, Lahey R, Cortes D, Olusanya Y, Hohm S, Tran H, Hess D, Nolta JA. Hepatocyte-Like Cells Can Be Derived from Human Umbilical Cord Blood and Embryonic Stem Cells: Tested in a Novel Mouse Model Blood. 112: 3490-3490. DOI: 10.1182/Blood.V112.11.3490.3490 |
0.471 |
|
| 2008 |
Anderson JS, Walker J, Wirthlin L, Javien J, Nolta JA, Bauer G. Evaluating the Safety and Efficacy of Anti-HIV Transgenic Cells in a Humanized Mouse Model (NOD/SCIDγc−/−) for HIV Stem Cell Gene Therapy. Blood. 112: 2352-2352. DOI: 10.1182/Blood.V112.11.2352.2352 |
0.416 |
|
| 2007 |
Nervi B, Rettig MP, Ritchey JK, Wang HL, Bauer G, Walker J, Bonyhadi ML, Berenson RJ, Prior JL, Piwnica-Worms D, Nolta JA, DiPersio JF. Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID beta2mnull mice. Experimental Hematology. 35: 1823-38. PMID 17764813 DOI: 10.1016/J.Exphem.2007.06.007 |
0.423 |
|
| 2007 |
Hess DA, Bonde J, Craft TP, Craft TC, Wirthlin L, Hohm S, Lahey R, Todt LM, Dipersio JF, Devine SM, Nolta JA. Human progenitor cells rapidly mobilized by AMD3100 repopulate NOD/SCID mice with increased frequency in comparison to cells from the same donor mobilized by granulocyte colony stimulating factor. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 13: 398-411. PMID 17382247 DOI: 10.1016/J.Bbmt.2006.12.445 |
0.414 |
|
| 2007 |
Dao MA, Creer MH, Nolta JA, Verfaillie CM. Biology of umbilical cord blood progenitors in bone marrow niches. Blood. 110: 74-81. PMID 17371947 DOI: 10.1182/Blood-2006-08-034447 |
0.392 |
|
| 2007 |
Partlow KC, Chen J, Brant JA, Neubauer AM, Meyerrose TE, Creer MH, Nolta JA, Caruthers SD, Lanza GM, Wickline SA. 19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 21: 1647-54. PMID 17284484 DOI: 10.1096/Fj.06-6505Com |
0.432 |
|
| 2007 |
Dao MA, Nolta JA. Cytokine and integrin stimulation synergize to promote higher levels of GATA-2, c-myb, and CD34 protein in primary human hematopoietic progenitors from bone marrow. Blood. 109: 2373-9. PMID 17095623 DOI: 10.1182/Blood-2006-05-026039 |
0.454 |
|
| 2007 |
Meyerrose TE, De Ugarte DA, Hofling AA, Herrbrich PE, Cordonnier TD, Shultz LD, Eagon JC, Wirthlin L, Sands MS, Hedrick MA, Nolta JA. In vivo distribution of human adipose-derived mesenchymal stem cells in novel xenotransplantation models. Stem Cells (Dayton, Ohio). 25: 220-7. PMID 16960135 DOI: 10.1634/Stemcells.2006-0243 |
0.486 |
|
| 2007 |
Zhou P, Hohm S, Hess DA, Nolta JA. Liver Engraftment by Transplanted Human Progenitor Cells with High Aldehyde Dehydrogenase Activity in a Novel Model, NOD/SCID/MPSVII Mice. Blood. 110: 434-434. DOI: 10.1182/Blood.V110.11.434.434 |
0.495 |
|
| 2007 |
Levac KD, Robson DL, Neelamkavil MJ, Hohm SA, Capoccia BJ, Link DC, Nolta JA, Hess DA. Aldehyde Dehydrogenase-Activity Purifies Multiple Hemangiogenic Lineages That Accelerate Vascularization of Ischemic Tissue through Paracrine Support of Neovessel Formation. Blood. 110: 3716-3716. DOI: 10.1182/Blood.V110.11.3716.3716 |
0.513 |
|
| 2007 |
Sondergaard C, Hess D, Rosova I, Hohm S, Wirthlin L, Lahey R, Lindsey M, Walker J, Bauer G, Zhou P, Nolta J. Adult Human Stem Cells Exert Therapeutic Effects To Repair Damaged Tissues in Xenograft Systems through Secretion of Trophic Factors Rather Than Direct Incorporation and Expansion. Blood. 110: 3693-3693. DOI: 10.1182/Blood.V110.11.3693.3693 |
0.521 |
|
| 2007 |
Rosova I, Nolta JA. Hypoxic Preconditioning Results in Increased Motility and Improved Therapeutic Potential of Human Mesenchymal Stem Cells in a Xenograft Hind Limb Ischemia Injury Model. Blood. 110: 217-217. DOI: 10.1182/Blood.V110.11.217.217 |
0.443 |
|
| 2007 |
Maxwell D, Hess D, Bonde J, Hohm SA, Lahey R, Creer M, Piwnica-Worms D, Nolta JA. Fluorophore Conjugated Iron Oxide Nanoparticle Labeling and Analysis of Engrafting Human Hematopoietic Stem Cells. Blood. 110: 1213-1213. DOI: 10.1182/Blood.V110.11.1213.1213 |
0.477 |
|
| 2007 |
Partlow KC, Brant JA, Marsh JN, Nolta JA, Hughes MS, Lanza GM, Wickline SA. Ultrasound energy markedly and rapidly effects stem/progenitor cell labeling with nanoparticle beacons for molecular imaging and cell tracking The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A379-B |
0.402 |
|
| 2007 |
Rettig M, Nervi B, Ritchey J, Prior J, Piwnica-Worms D, Wang H, Bauer G, Walker J, Bonyhadi M, Berenson R, Nolta J, DiPersio J. 322: In vivo bioluminescence and [18F]-FHBG micropet imaging studies of human T cell trafficking, expansion, and xenogeneic graft-versus-host-disease following different routes of human T cell administration Biology of Blood and Marrow Transplantation. 13: 117. DOI: 10.1016/J.Bbmt.2006.12.327 |
0.356 |
|
| 2006 |
Hess DA, Wirthlin L, Craft TP, Herrbrich PE, Hohm SA, Lahey R, Eades WC, Creer MH, Nolta JA. Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells. Blood. 107: 2162-9. PMID 16269619 DOI: 10.1182/Blood-2005-06-2284 |
0.439 |
|
| 2006 |
Nervi B, Rettig MP, Ritchey JK, Wang HL, Bauer G, Walker J, Prior JL, Piwnica-Worms D, Nolta JA, DiPersio JF. In Vivo Bioluminescence Imaging (BLI) and Sequential 18F]FHBG microPET Imaging Studies of Human T Cell (huT) Trafficking, Expansion and Xenogeneic Graft-Versus-Host-Disease (XGVHD) Following Different Routes of T Cell Administration. Blood. 108: 5178-5178. DOI: 10.1182/Blood.V108.11.5178.5178 |
0.434 |
|
| 2006 |
Devine S, Todt L, Bonde J, Hess D, Devine H, Nolta J, Link D, Calandra G, Bridger G, DiPersio J. A pilot study evaluating the safety and efficacy of AMD3100 for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells in patients with advanced hematological malignancies Biology of Blood and Marrow Transplantation. 12: 35. DOI: 10.1182/Blood.V104.11.3341.3341 |
0.339 |
|
| 2006 |
Bauer G, Walker J, Nervi B, Ritchey J, Rettig M, Hughes J, Eades B, Nolta J, DiPersio J. 1113. Large Scale Ex Vivo Expansion of Human T Cells under GMP Conditions Consistently Yields Fully Functional T Cells In Vivo Proven by Induction of Lethal GvHD in a Mouse Xenotransplant Model Molecular Therapy. 13: S428. DOI: 10.1016/J.Ymthe.2006.08.1219 |
0.389 |
|
| 2006 |
Nervi B, Rettig M, Ritchey J, Wang H, Bauer G, Walker J, Bonyhadi M, Berenson R, Herrbrich P, Hess D, Nolta J, DiPersio J. Ex vivo activated and transduced human T cells generate lethal GVHD in a mouse model, and are efficiently eliminated in vivo with suicide gene therapy Biology of Blood and Marrow Transplantation. 12: 53. DOI: 10.1016/J.Bbmt.2005.11.167 |
0.382 |
|
| 2006 |
Meyerrose T, Rosova I, Dao M, Herrbrich P, Bauer G, Nolta J. Establishment and transduction of primary human stromal/mesenchymal stem cell monolayers Genetic Engineering of Mesenchymal Stem Cells. 45-58. DOI: 10.1007/1-4020-3959-X_2 |
0.402 |
|
| 2006 |
Nolta JA. Genetic engineering of mesenchymal stem cells Genetic Engineering of Mesenchymal Stem Cells. 1-169. DOI: 10.1007/1-4020-3959-X |
0.401 |
|
| 2005 |
Sohara Y, Shimada H, Minkin C, Erdreich-Epstein A, Nolta JA, DeClerck YA. Bone marrow mesenchymal stem cells provide an alternate pathway of osteoclast activation and bone destruction by cancer cells. Cancer Research. 65: 1129-35. PMID 15734993 DOI: 10.1158/0008-5472.Can-04-2853 |
0.412 |
|
| 2005 |
Bauer G, Walker J, Nervi B, Ritchey J, Hughes J, Eades B, Bonyhadi M, Nolta J, DiPersio JF. Large Scale Ex Vivo GMP Expanded, Activated Human T Cells Consistently Induce Lethal GvHD in a Mouse Xenotransplant Model - A New Way To Study Treatments for Acute GvHD. Blood. 106: 5242-5242. DOI: 10.1182/Blood.V106.11.5242.5242 |
0.395 |
|
| 2005 |
Wirthlin L, Meyerrose TE, Creer MH, Nolta JA. Involvement of Lipid Raft Domain Signaling in Ex Vivo Maintenance of Hematopoietic Progenitor Cells. Blood. 106: 4216-4216. DOI: 10.1182/Blood.V106.11.4216.4216 |
0.48 |
|
| 2005 |
Nervi B, Rettig MP, Ritchey JK, Bauer G, Walker J, Hess D, Herrbrich PE, Bonyhadi M, Berenson RJ, Nolta JA, DiPersio JF. Naive and Ex Vivo Activated Human T Cells Generate Consistent Engraftment and Lethal Graft-Versus-Host Disease (GvHD) in NOD SCID β 2M Null Mice: A New Xenogeneic Model for GvHD. Blood. 106: 3106-3106. DOI: 10.1182/Blood.V106.11.3106.3106 |
0.392 |
|
| 2005 |
Bonde J, Maxwell DJ, Hess DA, Lahey R, Creer MH, Piwnica-Worms D, Nolta JA. In Vivo Imaging and Tracking of Defined, Repopulating Human Stem Cell Subsets Using Fluorescence Conjugated Nanoparticles in a Clinically Applicable Ex Vivo Protocol. Blood. 106: 3031-3031. DOI: 10.1182/Blood.V106.11.3031.3031 |
0.45 |
|
| 2005 |
Capoccia BJ, Wirthlin L, Shepherd R, O’Dell K, Nolta JA, Link DC, Hess DA. Bone Marrow-Derived Aldehyde Dehdrogenase Expressing Cells Possess Endothelial Progenitor Function in Addition to Hematopoietic Repopulating Ability and Aid in Blood Flow Recovery after Acute Ischemic Injury. Blood. 106: 2663-2663. DOI: 10.1182/Blood.V106.11.2663.2663 |
0.417 |
|
| 2005 |
Rosova I, Meyerrose TE, Nolta JA. Working Toward Better Tissue Repair Therapies: Exposure of MSC to Hypoxic Conditions In Vitro Increases Levels of the Hepatocyte Growth Factor Receptor c-met, Improves Motility, and Induces Phosphorylation of the Pro-Survival Protein AKT. Blood. 106: 2313-2313. DOI: 10.1182/Blood.V106.11.2313.2313 |
0.47 |
|
| 2005 |
Bonde J, Hess DA, Maxwell DJ, Lahey R, Creer MH, Piwnica-Worms D, Nolta JA. Comparison of Human Stem Cell Homing after Intravenous or Intra-Femoral Transplantation Using Multimodal In Vivo Imaging of Repopulating Human CD34+ Cells Labeled with Far-Red Fluorescent-Conjugated Nanoparticles. Blood. 106: 2196-2196. DOI: 10.1182/Blood.V106.11.2196.2196 |
0.442 |
|
| 2005 |
Hess DA, Wirthlin L, Craft TP, Bonde J, Lahey RW, Hohm SA, Herrbrich PE, DiPersio JF, Devine SM, Nolta JA. Human CD34+Cells Mobilized by AMD3100 Demonstrate Enhanced NOD/SCID Repopulating Function Compared to CD34+ Cells Mobilized by Granulocyte Colony Stimulating Factor. Blood. 106: 1962-1962. DOI: 10.1182/Blood.V106.11.1962.1962 |
0.44 |
|
| 2005 |
Hess DA, Wirthlin L, Craft TC, Herrbrich PE, Roberts M, Creer MH, Sands MS, Nolta JA. Transplanted Human Aldehyde Dehydrogenase Expressing Stem Cells Circulate and Engraft Nonhematopoietic Tissues. Blood. 106: 1693-1693. DOI: 10.1182/Blood.V106.11.1693.1693 |
0.493 |
|
| 2005 |
Herrbrich PE, Meyerrose TE, Nolta JA. Exploring the Molecular Mechanisms for Enhancing MSC Homing and Lodgement within Sites of Liver Damage/Fibrosis. Blood. 106: 1690-1690. DOI: 10.1182/Blood.V106.11.1690.1690 |
0.466 |
|
| 2005 |
Lahey R, Bonde J, Nolta JA. Uptake of Protamine Sulphate Complexed Fluorescent Nano-Particles Is Defined by Cell Cycle Status in Primary Human CD34+ Cells: Use of a Multi-Color p27 kip1 Based Flow Cytometric Assay. Blood. 106: 1363-1363. DOI: 10.1182/Blood.V106.11.1363.1363 |
0.439 |
|
| 2005 |
Meyerrose TE, Hope AJ, Lin SP, Herrbrich PE, Creer MH, Nolta JA. Tracking Differential Repopulation Kinetics of Human Hematopoietic Progenitor Cells Using MRI Detection of Nanoparticles. Blood. 106: 1274-1274. DOI: 10.1182/blood.v106.11.1274.1274 |
0.388 |
|
| 2005 |
Nolta JA, Jordan CT. The gold standard improves: A better assay for HSCs Blood. 106: 1141-1142. DOI: 10.1182/Blood-2005-05-2064 |
0.492 |
|
| 2005 |
Meyerrose TE, Herrbrich PE, Creer MH, Nolta JA. 1037. Adherent Human Umbilical Cord Blood Derived Mesenchymal Stem Cells Do Not Augment Viral Gene Transfer into Hematopoietic Stem/Progenitor Cells Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.584 |
0.492 |
|
| 2005 |
Meyerrose TE, Herrbrich PE, Creer MH, Nolta JA. 1032. Hepatocyte Growth Factor Maintains Hematopoietic Progenitors during Retroviral Transduction Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.579 |
0.454 |
|
| 2005 |
Hess DA, Wirthlin L, Craft TP, Herrbrich PE, Nolta JA. 1031. Purification of Cells with High Aldehyde Dehydrogenase Activity Reveals a CD133 Negative Population with Enhanced Repopulating Ability after Ex Vivo Culture Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.578 |
0.499 |
|
| 2005 |
Rosova I, Nolta JA. 927. Human Mesenchymal and Hematopoietic Stem Cell Contribution to Cardiac Tissue Regeneration after Injury Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.470 |
0.514 |
|
| 2005 |
Nervi B, Rettig MP, Ritchey JK, Bauer G, Walker J, Herrbrich PE, Meyerrose TE, Bonyhadi M, Nolta JA, DiPersio JF. 810. Ex-Vivo Activation and Genetic Manipulation of Human T Cells Results in Consistent In-Vivo Expansion and Lethal GvHD in a Novel Murine Xenotransplant Model Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.347 |
0.382 |
|
| 2005 |
Bonde J, Maxwell DJ, Hess DA, Lahey R, Piwnica-Worms D, Nolta JA. 783. Transient Transduction of Repopulating Human CD34+ Cells Using Nanoparticles in a Clinically Applicable Ex Vivo Protocol Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.322 |
0.415 |
|
| 2005 |
Hess DA, Craft TP, Wirthlin L, Herrbrich PE, Hofling AA, Sands MS, Nolta JA. 460. Transplantation of Human Aldehyde Dehydrogenase Expressing Cells Leads to Widespread Tissue Distribution of Donor Cells in the Pancreas and Liver of NOD/SCID/MPSVII Mice Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.468 |
0.497 |
|
| 2005 |
Dao MA, Nolta JA. 457. The Benefits of CH-296 during Ex Vivo Gene Transfer Go beyond the Ability to Co-Localize the Retroviral Particle and Target Cell Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.465 |
0.381 |
|
| 2005 |
Hope A, Meyerrose TE, Nolta JA. 353. Retrovirally-Marked Human Bone Marrow Derived Mesenchymal Stem Cells Attenuate Radiation Induced Pneumonitis in a Xenotransplant Model Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.356 |
0.385 |
|
| 2005 |
Bauer G, Walker J, Nervi B, Ritchey J, Hughes J, Eades B, Bonyhadi M, Nolta J, DiPersio J. 288. A System for GMP Expansion and Transduction of Human T Cells with High Functionality Proven by Consistent Induction of GvHD in a Mouse Xenotransplant Model Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.291 |
0.422 |
|
| 2005 |
Herrbrich PE, Meyerrose TE, Hofling AA, Sands M, Nolta JA. 243. Transplantation of Neonatal NOD/SCID/MPSVII Mice with Human Mesenchymal Stem Cells Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.246 |
0.498 |
|
| 2005 |
Bonde J, Maxwell DJ, Hess DA, Lahey R, Piwnica-Worms D, Nolta JA. 212. Differential, Transient Transduction of Defined Human Stem Cell Subsets Using Nanoparticles in a Clinically Applicable Ex Vivo Protocol Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.215 |
0.469 |
|
| 2005 |
Nervi B, Rettig M, Ritchey J, Walker J, Bauer G, Herrbrich P, Bonyhadi M, Nolta J, DiPersio J. Suicide gene therapy for human T cell mediated graft versus host disease in a murine xenograft model Biology of Blood and Marrow Transplantation. 11: 45-46. DOI: 10.1016/J.Bbmt.2004.12.135 |
0.355 |
|
| 2004 |
Bonde J, Hess DA, Nolta JA. Recent advances in hematopoietic stem cell biology. Current Opinion in Hematology. 11: 392-8. PMID 15548993 DOI: 10.1097/01.Moh.0000145672.42503.70 |
0.48 |
|
| 2004 |
Mohamedali A, Moreau-Gaudry F, Richard E, Xia P, Nolta J, Malik P. Self-inactivating lentiviral vectors resist proviral methylation but do not confer position-independent expression in hematopoietic stem cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. 10: 249-59. PMID 15294172 DOI: 10.1016/J.Ymthe.2004.05.002 |
0.402 |
|
| 2004 |
Hess DA, Meyerrose TE, Wirthlin L, Craft TP, Herrbrich PE, Creer MH, Nolta JA. Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood. 104: 1648-55. PMID 15178579 DOI: 10.1182/Blood-2004-02-0448 |
0.515 |
|
| 2004 |
Bonde J, Herrbrich P, Lahey R, Nolta JA. Use of Multi Color P27kip1 Based Flow Cytometric Assay To Evaluate and Characterize G0 to G1 Cell Cycle Related Changes in Human Hematopoietic Cells after Subjection to a Clinically Applicable Ex Vivo Transduction Protocol. Blood. 104: 5283-5283. DOI: 10.1182/Blood.V104.11.5283.5283 |
0.444 |
|
| 2004 |
Bauer G, Walker JE, Ritchey J, Nolta JA, DiPersio JF. GMP Scale up for a Clinical Gene Therapy Trial - High Efficiency Human T Cell Expansion and Transduction in a Closed Culture System Utilizing Serumfree Medium and Low IL-2 Concentrations. Blood. 104: 5250-5250. DOI: 10.1182/Blood.V104.11.5250.5250 |
0.417 |
|
| 2004 |
Nervi B, Rettig M, Ritchey J, Walker J, Bauer G, Herrbrich P, Bonyhadi ML, Nolta JA, DiPersio JF. In Vivo Suicide Gene Therapy of Human T Lymphocytes To Prevent Graft Versus Host Disease in a Murine Xenograft Model. Blood. 104: 4979-4979. DOI: 10.1182/Blood.V104.11.4979.4979 |
0.405 |
|
| 2004 |
Nervi B, Rettig M, Ritchey J, Walker J, Bauer G, Herrbrich P, Nolta JA, DiPersio JF. A Murine Xenograft Model for Human T Cell Mediated Graft Versus Host Disease. Blood. 104: 4977-4977. DOI: 10.1182/Blood.V104.11.4977.4977 |
0.404 |
|
| 2004 |
Hess DA, Craft TP, Wirthlin L, Herrbrich PE, Hofling AA, Sands MS, Nolta JA. Transplantation of Human Aldehyde Dehydrogenase Expressing Cells Leads to Widespread Tissue Distribution of Donor Cells in the Novel NOD/SCID/MPSVII Xenotransplantation Model. Blood. 104: 3601-3601. DOI: 10.1182/Blood.V104.11.3601.3601 |
0.486 |
|
| 2004 |
Hess DA, Herrbrich PE, Wirthlin L, Craft TP, Nolta JA. Isolation of Human CD34- Cells with High Aldehyde Dehydrogenase Activity Reveals a Novel Population with Hematopoietic Repopulating Potential. Blood. 104: 3214-3214. DOI: 10.1182/Blood.V104.11.3214.3214 |
0.487 |
|
| 2004 |
Bonde J, Hess DA, DiPersio JF, Nolta JA, Devine SM. Multilineage Analysis of Paired AMD-3100 and G-CSF Mobilized-Peripheral Blood Stem Cell Products from Healthy Donors Undergoing Clinical Mobilization: A Pilot Study. Blood. 104: 2848-2848. DOI: 10.1182/Blood.V104.11.2848.2848 |
0.4 |
|
| 2004 |
Hess DA, Wirthlin L, Craft TP, Meyerrose TE, Nolta JA. CD133-Expressing Cells with High Aldehyde Dehydrogenase Activity Represent a Primitive Human Hematopoietic Stem Cell Population with Enhanced Repopulating Potential. Blood. 104: 250-250. DOI: 10.1182/Blood.V104.11.250.250 |
0.41 |
|
| 2004 |
Hess DA, Bonde J, Craft TP, Wirthlin L, DiPersio JF, Devine SM, Nolta JA. Human CD34+ Cells Rapidly Mobilized by AMD3100 Repopulate NOD/SCID Mice with Equivalent Efficiency as CD34+ Cells Mobilized by G-CSF. Blood. 104: 1186-1186. DOI: 10.1182/Blood.V104.11.1186.1186 |
0.434 |
|
| 2004 |
Nolta J. Improved method to bridge mouse and man Blood. 103: 370-371. DOI: 10.1182/Blood-2003-10-3634 |
0.493 |
|
| 2004 |
Hess DA, Meyerrose TE, Wirthlin L, Herrbrich PE, Craft TP, Nolta JA. 898. Human hematopoietic repopulating stem and progenitor cells can be efficiently selected based on high aldehyde dehydrogenase activity Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.804 |
0.488 |
|
| 2004 |
Nervi B, Rettig M, Ritchey J, Walker J, Bauer G, Herrbrich P, Nolta JA, DiPersio JF. 259. In Vivo Suicide Gene Therapy of Human T Lymphocytes in a Murine Xenograft Model Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.200 |
0.382 |
|
| 2004 |
Walker JE, Bauer G, Herrbrich P, Hess D, Meyerrose T, Nervi B, Rettig M, Nolta JA, DiPersio JF. 606. The NOD-SCID |[beta]|2M null mouse xenograft model for studying activation, expansion and GvHD potential of gene transduced human t cells in vivo Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.1010 |
0.417 |
|
| 2003 |
Meyerrose TE, Herrbrich P, Hess DA, Nolta JA. Immune-deficient mouse models for analysis of human stem cells. Biotechniques. 35: 1262-72. PMID 14682062 DOI: 10.2144/03356Ss06 |
0.494 |
|
| 2003 |
Kohn DB, Sadelain M, Dunbar C, Bodine D, Kiem HP, Candotti F, Tisdale J, Riviére I, Blau CA, Richard RE, Sorrentino B, Nolta J, Malech H, Brenner M, Cornetta K, et al. American Society of Gene Therapy (ASGT) ad hoc subcommittee on retroviral-mediated gene transfer to hematopoietic stem cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. 8: 180-7. PMID 12907140 DOI: 10.1016/S1525-0016(03)00212-0 |
0.389 |
|
| 2003 |
Schmidt M, Carbonaro DA, Speckmann C, Wissler M, Bohnsack J, Elder M, Aronow BJ, Nolta JA, Kohn DB, von Kalle C. Clonality analysis after retroviral-mediated gene transfer to CD34+ cells from the cord blood of ADA-deficient SCID neonates. Nature Medicine. 9: 463-8. PMID 12640448 DOI: 10.1038/Nm844 |
0.408 |
|
| 2003 |
Wu GD, Nolta JA, Jin YS, Barr ML, Yu H, Starnes VA, Cramer DV. Migration of mesenchymal stem cells to heart allografts during chronic rejection. Transplantation. 75: 679-85. PMID 12640309 DOI: 10.1097/01.Tp.0000048488.35010.95 |
0.489 |
|
| 2003 |
Wang X, Ge S, McNamara G, Hao QL, Crooks GM, Nolta JA. Albumin-expressing hepatocyte-like cells develop in the livers of immune-deficient mice that received transplants of highly purified human hematopoietic stem cells. Blood. 101: 4201-8. PMID 12560238 DOI: 10.1182/Blood-2002-05-1338 |
0.473 |
|
| 2003 |
Dao MA, Arevalo J, Nolta JA. Reversibility of CD34 expression on human hematopoietic stem cells that retain the capacity for secondary reconstitution. Blood. 101: 112-8. PMID 12393633 DOI: 10.1182/Blood-2002-01-0025 |
0.428 |
|
| 2003 |
Wu G, Nolta J, Jin Y, Barr M, Starnes V, Cramer D. Migration of mesenchymal progenitors to heart allograft: evidence for active participation of mesenchymal stem cells in tissue repair and inadvertent attribution to graft fibrosis The Journal of Heart and Lung Transplantation. 22: S125. DOI: 10.1016/S1053-2498(02)00853-7 |
0.43 |
|
| 2002 |
Dao MA, Nolta JA. Retroviral-mediated transduction and clonal integration analysis of human hematopoietic stem and progenitor cells. Methods in Molecular Medicine. 63: 253-74. PMID 21437813 DOI: 10.1385/1-59259-140-X:253 |
0.446 |
|
| 2002 |
Gussoni E, Bennett RR, Muskiewicz KR, Meyerrose T, Nolta JA, Gilgoff I, Stein J, Chan YM, Lidov HG, Bönnemann CG, Von Moers A, Morris GE, Den Dunnen JT, Chamberlain JS, Kunkel LM, et al. Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation. The Journal of Clinical Investigation. 110: 807-14. PMID 12235112 DOI: 10.1172/Jci16098 |
0.333 |
|
| 2002 |
Nolta JA, Thiemann FT, Arakawa-Hoyt J, Dao MA, Barsky LW, Moore KA, Lemischka IR, Crooks GM. The AFT024 stromal cell line supports long-term ex vivo maintenance of engrafting multipotent human hematopoietic progenitors Leukemia. 16: 352-361. PMID 11896538 DOI: 10.1038/sj/leu/2402371 |
0.361 |
|
| 2002 |
Dao MA, Hwa J, Nolta JA. Molecular mechanism of transforming growth factor beta-mediated cell-cycle modulation in primary human CD34(+) progenitors. Blood. 99: 499-506. PMID 11781230 DOI: 10.1182/Blood.V99.2.499 |
0.371 |
|
| 2001 |
Nolta JA, Jordan CT. Spotlight on hematopoietic stem cells: looking beyond dogma. Introduction. Leukemia. 15: 1677-80. PMID 11681405 |
0.4 |
|
| 2001 |
Wang X, Dao MA, Kuo I, Nolta JA. Phenotypic comparison of extrathymic human bone-marrow-derived T cells with thymic-selected T cells recovered from different tissues Clinical Immunology. 100: 339-348. PMID 11513547 DOI: 10.1006/Clim.2001.5068 |
0.391 |
|
| 2001 |
Tsark EC, Dao MA, Wang X, Weinberg K, Nolta JA. IL-7 enhances the responsiveness of human T cells that develop in the bone marrow of athymic mice Journal of Immunology. 166: 170-181. PMID 11123290 DOI: 10.4049/Jimmunol.166.1.170 |
0.398 |
|
| 2001 |
Nolta JA, Kohn DB. UNIT 13.7 Human Hematopoietic Cell Culture, Transduction, and Analyses Current Protocols in Human Genetics. DOI: 10.1002/0471142905.Hg1307S14 |
0.419 |
|
| 2000 |
Dao MA, Nolta JA. CD34: To select or not to select? That is the question Leukemia. 14: 773-776. PMID 10803504 DOI: 10.1038/Sj.Leu.2401781 |
0.47 |
|
| 2000 |
Parkman R, Weinberg K, Nolta J, Kapoor N, Kohn D. Gene Therapy for Adenosine Deaminase Deficiency Annual Review of Medicine. 51: 33-47. PMID 10774451 DOI: 10.1146/Annurev.Med.51.1.33 |
0.399 |
|
| 2000 |
Wang X, Hong R, Nolta J. Extrathymic human t lymphocyte development and regulation in immune deficient mice Experimental Hematology. 28: 1500. DOI: 10.1016/S0301-472X(00)00581-6 |
0.4 |
|
| 2000 |
Dao MA, Nolta JA. Integrin engagement on fibronectin modulates the protein levels of c-myb, CD34, P21, and P130 in primary human hematopoietic progenitors Experimental Hematology. 28: 59. DOI: 10.1016/S0301-472X(00)00273-3 |
0.463 |
|
| 2000 |
Dao M, Tsark E, Ertl D, Wang X, Kim T, Malik P, Kohn D, Nolta J. Engineered cytokine secretion from human mesenchymal stem cells influences in vivo hematopoiesis Experimental Hematology. 28: 59. DOI: 10.1016/S0301-472X(00)00272-1 |
0.443 |
|
| 2000 |
Arevalo JMG, Case SS, Kohn DB, Nolta JA. Effects of allogeneic support cells on human hematopoietic stem cell engraftment in a novel immune deficient mouse transplant system Blood. 96: 172a-173a. |
0.386 |
|
| 1999 |
Dao MA, Tsark E, Nolta JA. Animal xenograft models for evaluation of gene transfer into human hematopoietic stem cells Current Opinion in Molecular Therapeutics. 1: 553-557. PMID 11249661 |
0.425 |
|
| 1999 |
Dao MA, Nolta JA. Molecular control of cell cycle progression in primary human hematopoietic stem cells: Methods to increase levels of retroviral-mediated transduction Leukemia. 13: 1473-1480. PMID 10516745 DOI: 10.1038/Sj.Leu.2401537 |
0.504 |
|
| 1999 |
Dao MA, Nolta JA. Immunodeficient mice as models of human hematapoietic stem cell engraftment Current Opinion in Immunology. 11: 532-537. PMID 10508705 DOI: 10.1016/S0952-7915(99)00006-0 |
0.491 |
|
| 1998 |
Dunbar CE, Kohn DB, Schiffmann R, Barton NW, Nolta JA, Esplin JA, Pensiero M, Long Z, Lockey C, Emmons RV, Csik S, Leitman S, Krebs CB, Carter C, Brady RO, et al. Retroviral transfer of the glucocerebrosidase gene into CD34+ cells from patients with Gaucher disease: in vivo detection of transduced cells without myeloablation. Human Gene Therapy. 9: 2629-40. PMID 9853529 DOI: 10.1089/Hum.1998.9.17-2629 |
0.455 |
|
| 1998 |
Dao MA, Nolta JA. Use of the bnx/hu xenograft model of human hematopoiesis to optimize methods for retroviral-mediated stem cell transduction (Review) International Journal of Molecular Medicine. 1: 257-264. PMID 9852228 DOI: 10.3892/Ijmm.1.1.257 |
0.539 |
|
| 1998 |
Dao MA, Hashino K, Kato I, Nolta JA. Adhesion to fibronectin maintains regenerative capacity during ex vivo culture and transduction of human hematopoietic stem and progenitor cells Blood. 92: 4612-4621. PMID 9845527 DOI: 10.1182/Blood.V92.12.4612 |
0.516 |
|
| 1998 |
Dao MA, Taylor N, Nolta JA. Reduction in levels of the cyclin-dependent kinase inhibitor p27(kip-1) coupled with transforming growth factor β neutralization induces cell-cycle entry and increases retroviral transduction of primitive human hematopoietic cells Proceedings of the National Academy of Sciences of the United States of America. 95: 13006-13011. PMID 9789031 DOI: 10.1073/Pnas.95.22.13006 |
0.424 |
|
| 1998 |
Dao MA, Shah AJ, Crooks GM, Nolta JA. Engraftment and retroviral marking of CD34+ and CD34+ CD38- human hematopoietic progenitors assessed in immune-deficient mice Blood. 91: 1243-1255. PMID 9454754 DOI: 10.1182/Blood.V91.4.1243 |
0.39 |
|
| 1998 |
Dao MA, Nolta JA. Hematopoietic stem cells as targets for human gene therapy Cancer Research Therapy and Control. 7: 19-25. |
0.366 |
|
| 1997 |
Dao MA, Xiao Jin Yu, Nolta JA. Clonal diversity of primitive human hematopoietic progenitors following retroviral marking and long-term engraftment in immune-deficient mice Experimental Hematology. 25: 1357-1366. PMID 9406995 |
0.392 |
|
| 1997 |
Dao MA, Pepper KA, Nolta JA. Long-term cytokine production from engineered primary human stromal cells influences human hematopoiesis in an in vivo xenograft model. Stem Cells (Dayton, Ohio). 15: 443-54. PMID 9402657 DOI: 10.1002/Stem.150443 |
0.443 |
|
| 1997 |
Dao MA, Hannum CH, Kohn DB, Nolta JA. FLT3 ligand preserves the ability of human CD34+ progenitors to sustain long-term hematopoiesis in immune-deficient mice after ex vivo retroviral- mediated transduction Blood. 89: 446-456. PMID 9002946 DOI: 10.1182/Blood.V89.2.446 |
0.425 |
|
| 1997 |
Nolta JA, Kohn DB. 15 – Haematopoietic stem cells for gene therapy Stem Cells. 447-462. DOI: 10.1016/B978-012563455-7/50016-7 |
0.442 |
|
| 1997 |
Dao MA, Nolta JA. Effect of tgfβ on human cd34+ progenitors on fibronectin at the cell cycle level Experimental Hematology. 25: 753. |
0.348 |
|
| 1997 |
Oki MA, Nolta JA. Modulation of the extent of ritrovtral-mediated transduction of human hematopotic progenitors by antcense p271"" and amti tgfp antibody Experimental Hematology. 25: 881. |
0.405 |
|
| 1996 |
Dunbar PIC, Kohn D, Karlsson SCS, Barton IN, Brady R, Cottler-Fox M, Emmons R, Esplin J, Leitman S, Lenarsky C, Nolta J, Parkman R, Pensiero M, Schifmann R, Tolstoshev P, et al. Retroviral Mediated Transfer of the cDNA for Human Glucocerebrosidase into Hematopoietic Stem Cells of Patients with Gaucher Disease. A Phase I Study. National Institutes of Health, Bethesda, Maryland Human Gene Therapy. 7: 231-253. PMID 8788174 DOI: 10.1089/Hum.1996.7.2-231 |
0.501 |
|
| 1996 |
Nolta JA, Dao MA, Wells S, Smogorzewska EM, Kohn DB. Transduction of pluripotent human hematopoietic stem cells demonstrated by clonal analysis after engraftment in immune-deficient mice Proceedings of the National Academy of Sciences of the United States of America. 93: 2414-2419. PMID 8637888 DOI: 10.1073/Pnas.93.6.2414 |
0.473 |
|
| 1996 |
Bolotin E, Nolta J, Smith S, Dao M, Weinberg K. EFFECTIVE IMMUNE RECONSTITUTION IN MICE AFTER CO-TRANSPLANTATION OF BONE MARROW AND MARROW STROMA TRANSDUCED WITH THE IL-7 GENE: GENE THERAPY FOR POST-BMT IMMUNE DEFICIENCY. • 40 Pediatric Research. 39: 9-9. DOI: 10.1203/00006450-199604001-00059 |
0.357 |
|
| 1996 |
Dao M, Wiltshire LL, Pepper KA, Nolta JA. Human cytokine production from engineered stromal cells influences lineage development from CO-transplanted human CD 34' progenitors Experimental Hematology. 24: 1117. |
0.301 |
|
| 1995 |
Wells S, Malik P, Pensiero M, Kohn DB, Nolta JA. The presence of an autologous marrow stromal cell layer increases glucocerebrosidase gene transduction of long-term culture initiating cells (LTCICs) from the bone marrow of a patient with Gaucher disease. Gene Therapy. 2: 512-20. PMID 8593601 |
0.334 |
|
| 1995 |
Nolta JA, Smogorzewska EM, Kohn DB. Analysis of optimal conditions for retroviral-mediated transduction of primitive human hematopoietic cells Blood. 86: 101-110. PMID 7795215 |
0.377 |
|
| 1995 |
Kohn DB, Weinberg KI, Nolta JA, Heiss LN, Lenarsky C, Crooks GM, Hanley ME, Annett G, Brooks JS, El-Khoureiy A, Lawrence K, Wells S, Moen RC, Bastian J, Williams-Herman DE, et al. Engraftment of gene–modified umbilical cord blood cells in neonates with adenosine deaminase deficiency Nature Medicine. 1: 1017-1023. PMID 7489356 DOI: 10.1038/nm1095-1017 |
0.302 |
|
| 1995 |
Nolta J, Smogorzewska E, Kohn D. Analysis of optimal conditions for retroviral-mediated transduction of primitive human hematopoietic cells Blood. 86: 101-110. DOI: 10.1182/Blood.V86.1.101.Bloodjournal861101 |
0.478 |
|
| 1994 |
Nolta JA, Hanley MB, Kohn DB. Sustained human hematopoiesis in immunodeficient mice by cotransplantation of marrow stroma expressing human interleukin-3: Analysis of gene transduction of long-lived progenitors Blood. 83: 3041-3051. PMID 7514050 |
0.354 |
|
| 1994 |
Nolta JA, Hanley MB, Kohn DB. Sustained human hematopoiesis in immunodeficient mice by cotransplantation of marrow stroma expressing human interleukin-3: analysis of gene transduction of long-lived progenitors Blood. 83: 3041-3051. DOI: 10.1182/Blood.V83.10.3041.3041 |
0.459 |
|
| 1992 |
Nolta JA, Yu XJ, Bahner I, Kohn DB. Retroviral-mediated transfer of the human glucocerebrosidase gene into cultured gaucher bone marrow Journal of Clinical Investigation. 90: 342-348. PMID 1379609 DOI: 10.1172/Jci115868 |
0.449 |
|
| 1992 |
Nolta JA, Crooks GM, Overell RW, Williams DE, Kohn DB. Retroviral vector-mediated gene transfer into primitive human hematopoietic progenitor cells: Effects of mast cell growth factor (MGF) combined with other cytokines Experimental Hematology. 20: 1065-1071. PMID 1281784 |
0.317 |
|
| 1991 |
Kohn DB, Nolta JA, Weinthal J, Bahner I, Yu XJ, Lilley J, Crooks GM. Toward gene therapy for Gaucher disease. Human Gene Therapy. 2: 101-5. PMID 1911928 DOI: 10.1089/Hum.1991.2.2-101 |
0.437 |
|
| 1991 |
Weinthal J, Nolta JA, Yu XJ, Lilley J, Uribe L, Kohn DB. Expression of human glucocerebrosidase following retroviral vector-mediated transduction of murine hematopoietic stem cells. Bone Marrow Transplantation. 8: 403-12. PMID 1768976 |
0.325 |
|
| 1990 |
Nolta JA, Kohn DB. Comparison of the effects of growth factors on retroviral vector-mediated gene transfer and the proliferative status of human hematopoietic progenitor cells Human Gene Therapy. 1: 257-268. PMID 2081193 DOI: 10.1089/Hum.1990.1.3-257 |
0.354 |
|
| 1990 |
Nolta J, Sender LS, Barranger JA, Kohn DB. Expression of human glucocerebrosidase in murine long-term bone marrow cultures after retroviral vector-mediated transfer. Blood. 75: 787-797. DOI: 10.1182/Blood.V75.3.787.787 |
0.375 |
|
| Show low-probability matches. |